Drimva

Benchling

Leader, Majors Sales

$182K–$494K

New York, NY +3 · Hybrid · Full-time · Posted Oct 22, 2026

Location
New York, NY
San Francisco, CA
Philadelphia, PA
Boston, MA
Experience
10+ years of enterprise complex SaaS sales experience, including 3+ years managing a team of field AEs.
Education
Bachelor’s in a life sciences field (or equivalent experience); advanced degree a plus.

About the job

Leads a team of enterprise account executives selling Benchling’s platform to major global biotechnology companies, overseeing pipeline growth, sales execution, and account expansion.

What you'll do

  • Recruit, coach, and develop Major Account Executives; guide them through new-business and expansion sales.
  • Manage pipeline generation, forecasts, deal inspection, and account planning across the team.
  • Build executive relationships and partner cross-functionally to deliver customer outcomes and inform go-to-market strategy.

What they ask for

  • 10+ years of enterprise complex SaaS sales experience, including 3+ years managing field AEs focused on a small number of large, complex global accounts (1–5 each).
  • Track record of consistent quota attainment as a seller and leader; experience driving weekly pipeline generation and AE self-sourced pipeline.
  • Experience leading value-based sales cycles using MEDDICC or a comparable framework, and closing large deals involving procurement, legal, and security review.
  • Experience with expansion, renewal, or consumption-based models in an installed base.

Nice to have

  • Experience selling scientific or R&D software into biopharma.
  • Bachelor’s in a life sciences field (or equivalent experience); advanced degree a plus.

Pay

$182,000 - $247,000 USD base salary; $364,000 - $494,000 USD total on-target earnings

Tools

SaaS, MEDDICC, LIMS, ELN

AI focus

The interview process includes a brief AI-focused exercise or discussion about how the candidate thinks about and uses AI to drive impact in the role.

Model-written summary · the original posting is authoritative

First seen Oct 23, 2026 · Last verified Nov 5, 2026 (UTC)